Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 242 of 5804
-
AI Doctor's helper: could a smart system improve heart and diabetes care?
Disease control Not yet recruitingThis study aims to evaluate the effectiveness of a large language model (LLM)-supported, community-based integrated management model in improving cardiometabolic multimorbidity control among adults with hypertension and coexisting diabetes or dyslipidemia. Adopting an interventio…
Phase: NA • Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Hormone showdown: which progestin best tames uterine cancer before surgery?
Disease control Recruiting nowThis phase II trial tests compares the effect of progestins, megestrol acetate to micronized progesterone, in treating patients with endometrial cancer and precancers of the uterus (atypical endometrial hyperplasia) before surgery. Progestins, similar to the natural hormone proge…
Phase: PHASE2 • Sponsor: New Mexico Cancer Research Alliance • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New magnetic device aims to boost stroke recovery
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate whether low-frequency, low-intensity transcranial magnetic stimulation (ELF-MF), delivered by the I-NIC medical device, is effective and safe in treating patients with acute ischemic stroke. The study aims to answer the following qu…
Phase: NA • Sponsor: IGEA • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
AI eye on lung cancer: new study tests smart screening for High-Risk families
Diagnosis Not yet recruitingThis research is being done to determine if an image-based deep learning model (Sybil) can accurately predict the likelihood of future lung cancer based on chest computed tomography (CT) imaging from individuals with a family history of lung cancer.
Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
Immunotherapy-Chemo cocktail shows promise for shrinking cervical tumors before surgery
Disease control Not yet recruitingThis is a prospective, single-arm, phase II clinical study designed to evaluate the efficacy and safety of QL1706 combined with cisplatin and paclitaxel as neoadjuvant therapy in patients with FIGO 2018 stage IB1-IB3 cervical cancer undergoing conservative surgery. The primary e…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo ablation aims to tame stubborn AFib
Disease control Not yet recruitingThe goal of this clinical trial is to test if a more complete ablation procedure works better than the standard procedure for people with long-lasting atrial fibrillation (AF). AF is a heart rhythm problem that can cause a fast or uneven heartbeat. This study will include 430 pe…
Phase: NA • Sponsor: Yunlong Wang • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Radiation plus immunotherapy shows promise in bile duct cancer trial
Disease control Not yet recruitingAccording to current clinical guidelines, first-line treatment for advanced biliary tract cancer (BTC) is the gemcitabine plus cisplatin (GC) regimen combined with immunotherapy, which has been shown to improve patient outcomes. Additionally, the combination of radiotherapy and i…
Phase: PHASE2 • Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
AI blood test could spot deadly clotting complication in sepsis patients
Diagnosis Not yet recruitingDisseminated Intravascular Coagulation is a severe complication of septic shock, associated with high mortality, whose diagnosis relies on complex scores that are rarely used in practice. Preliminary studies have shown that increased neutrophil fluorescence is associated with Dis…
Sponsor: University Hospital, Strasbourg, France • Aim: Diagnosis
Last updated Jun 27, 2026 13:03 UTC
-
Could a shot replace daily HIV pills? new trial tests Two-Injection combo
Disease control Recruiting nowThe study will have two parts: Part A and Part B. In Part A, the goal of the study is to compare the effectiveness of switching to the study drugs GS-3242 plus Lenacapavir (LEN) versus continuing Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF)), in virological…
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Triple-Drug attack on stomach cancer shows promise in major trial
Disease control Not yet recruitingThis is a Randomized, Double-Blind, Phase II/III Clinical Study of the Efficacy and Safety of Sintilimab Combined with Chemotherapy With or Without Ipilimumab N01 in Perioperative Treatment of Resectable Gastric/Gastroesophageal Junction Adenocarcinoma.
Phase: PHASE2, PHASE3 • Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug combo may boost surgery success in returning liver cancer
Disease control Not yet recruitingThis is a single-arm, phase II clinical study designed to evaluate the efficacy and safety of a recombinant PD-1/IL-2 bispecific antibody, as neoadjuvant therapy in hepatocellular carcinoma (HCC) patients who experienced early recurrence after curative hepatectomy and were suitab…
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New Three-Drug cocktail aims to wipe out stomach cancer before surgery
Disease control Not yet recruitingThe purpose of this clinical trial is to evaluate whether perioperative fruquintinib combined with sintilimab and SOX is effective in treating locally advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma. The study will also assess the safety profile of this treatme…
Phase: PHASE2 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New pill shows promise for Hard-to-Treat ovarian cancer
Disease control Not yet recruitingThis is a Phase II, multicenter, single-arm dose expansion trial planned to enroll up to 30 subjects with advanced or metastatic ovarian cancer. The Objective is to conduct a preliminary evaluation of the efficacy, the safety, tolerability and PK profile of DAT-2645
Phase: PHASE2 • Sponsor: Danatlas Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New minimally invasive technique may spare spinal fracture patients from major surgery
Disease control Not yet recruitingThis study evaluates minimally invasive vertebral augmentation combined with percutaneous fixation for the treatment of severe thoracolumbar burst fractures. Traditionally, fractures with a Load Sharing Classification (LSC) score ≥7 require corpectomy, which is associated with si…
Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug cocktail aims to shrink Hard-to-Treat colorectal tumors
Disease control ENROLLING_BY_INVITATIONA New Treatment Opportunity for Patients with Advanced Colorectal Cancer Refractory to Standard Chemotherapy: Clinical Trial of Capecitabine plus Lenvatinib Combination Therapy
Phase: PHASE1, PHASE2 • Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Spinal stimulation may restore cough power after paralysis
Disease control ENROLLING_BY_INVITATIONThe overall objective of this proposal is to determine if transcutaneous spinal cord stimulation (tSCS) delivered concurrently with functional electrical stimulation (FES)-assisted cough training (FES-Cough) is an effective intervention to improve cough strength and coordination …
Phase: NA • Sponsor: Milap Sandhu • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
App-Based therapy aims to curb Self-Harm in teens
Disease control Not yet recruitingThe goal of this randomized, parallel-controlled clinical trial is to investigate multi-dimensional biomarkers (blood, brain imaging, clinical information, and symptom assessment) in adolescents with Non-Suicidal Self-Injury (NSSI) and to evaluate the therapeutic and prognostic e…
Phase: NA • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Targeted pill aims to shrink brain tumors with BRAF mutations
Disease control Recruiting nowThis is a Phase 2, open-label, single-arm clinical study designed to evaluate the efficacy and safety of Belvarafenib in patients with BRAF-altered primary brain tumors (Cohort 1) and metastatic brain tumors (Cohort 2). Eligible patients are those with a confirmed BRAF alteration…
Phase: PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a chicory root fiber supercharge immunotherapy against skin cancer?
Disease control Not yet recruitingPrevious research has shown that a higher fiber intake may have a beneficial effect on the intestinal health and improve the effectiveness of immunotherapy, but this is not certain. The objective of this double-blinded randomized clinical trial is to analyze, whether increased di…
Phase: PHASE2 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Experimental injection aims to combat Life-Threatening liver failure
Disease control Recruiting now\*\*Document Name: This Trial is a Phase II Clinical Study.docx\*\* \*\*Document Content:\*\* * This trial is a Phase II clinical study, conducted in two stages: * \*\*Phase IIa:\*\* A sentinel, single-arm design will be employed. A total of 12 early ACLF subjects are expected t…
Phase: PHASE2 • Sponsor: Shenzhen Third People's Hospital • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC